In March 2025, the company introduced new strategies for the immediate-to-consumer supplying of its Wegovy weight loss drug. The company recognized a new pharmacy, referred to as NovoCare, which might cost buyers $499 every month for access to the drug, lower than half the expense of the drug by other pharmaceutical distribution networks.[fifty thr